Paper · 8030745
Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences.
Kim H and 3 others. Am J Pathol, 1994. Cited by 753 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Papers, record 8030745. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8030745
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma | Major topic |
| Colorectal Neoplasms | Major topic |
| DNA Replication | Major topic |
| DNA, Neoplasm | Major topic |
| DNA, Satellite | Major topic |
| Adult | |
| Age Factors | |
| Aged | |
| Aged, 80 and over | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Prospective Studies |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P50 CA62924 | NCI NIH HHS | United States | P50CA062924 | PubMed and NIH | NIH RePORTER |
| R01 CA47527 | NCI NIH HHS | United States | R01CA047527 | PubMed and NIH | NIH RePORTER |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 10,980,144 | Genetic and epigenetic modification of MLH1. | https://conductscience.org/library/papers/10980144 |
Source PubMed
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2,876,925 | Oncogene alterations in primary human colon tumors. | Gastroenterology | 1986 | https://conductscience.org/library/papers/2876925 | PubMed |
| 2 | 2,362,940 | Crohn's-like lymphoid reaction and colorectal carcinoma: a potential histologic prognosticator. | Mod Pathol | 1990 | https://conductscience.org/library/papers/2362940 | PubMed |
| 3 | 3,557,013 | Protooncogene abnormalities in colon cancers and adenomatous polyps. | Gastroenterology | 1987 | https://conductscience.org/library/papers/3557013 | PubMed |
| 4 | 2,884,421 | A new prognostic classification of rectal cancer. | Lancet | 1987 | https://conductscience.org/library/papers/2884421 | PubMed |
| 5 | 3,587,348 | Prevalence of ras gene mutations in human colorectal cancers. | Nature | 1987 | https://conductscience.org/library/papers/3587348 | PubMed |
| 6 | 3,422,035 | A multivariate analysis of pathologic prognostic indicators in large bowel cancer. | Cancer | 1988 | https://conductscience.org/library/papers/3422035 | PubMed |
| 7 | 2,832,726 | Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. | Mol Cell Biol | 1988 | https://conductscience.org/library/papers/2832726 | PubMed |
| 8 | 2,649,981 | Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. | Science | 1989 | https://conductscience.org/library/papers/2649981 | PubMed |
| 9 | 1,699,228 | p53 mutations in colorectal cancer. | Proc Natl Acad Sci U S A | 1990 | https://conductscience.org/library/papers/1699228 | PubMed |
| 10 | 2,240,880 | Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. | Ann Intern Med | 1990 | https://conductscience.org/library/papers/2240880 | PubMed |
1 to 10 of 34
See all 34 referencesCited by241
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 753 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,488,413 | The characteristics of gut microbiota in colorectal cancer with different microsatellite states. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42488413 | PubMed |
| 41,486,293 | Targeting PTPN13 with 11-amino-acid peptides of C-terminal APC prevents immune evasion of colorectal cancer. | Cell Res | 2026 | https://conductscience.org/library/papers/41486293 | PubMed |
| 40,914,748 | Harnessing biomarkers to guide immunotherapy in esophageal cancer: toward precision oncology. | Clin Transl Oncol | 2026 | https://conductscience.org/library/papers/40914748 | PubMed |
| 40,640,471 | Therapeutic targeting of mismatch repair-deficient cancers. | Nat Rev Clin Oncol | 2025 | https://conductscience.org/library/papers/40640471 | PubMed |
| 40,265,527 | Intrinsic Properties of the Lymph Node Render It Immunologically Susceptible to Metastasis. | Cancer Discov | 2025 | https://conductscience.org/library/papers/40265527 | PubMed |
| 39,857,073 | Effects of Microsatellite Instability on the Clinical and Pathological Characteristics of Colon Cancer and the Diagnostic Accuracy of Preoperative Abdominal CT Scans. | Diagnostics (Basel) | 2025 | https://conductscience.org/library/papers/39857073 | PubMed |
| 39,852,970 | The Role of Indoxyl Sulfate in Exacerbating Colorectal Cancer During Chronic Kidney Disease Progression: Insights into the Akt/β-Catenin/c-Myc and AhR/c-Myc Pathways in HCT-116 Colorectal Cancer Cells. | Toxins (Basel) | 2025 | https://conductscience.org/library/papers/39852970 | PubMed |
| 39,321,179 | Liver metastases and peritoneal metastases and response to checkpoint inhibitors in metastatic colorectal cancer with microsatellite instability. | Oncologist | 2024 | https://conductscience.org/library/papers/39321179 | PubMed |
| 39,212,927 | Gastrointestinal Malignancy: Genetic Implications to Clinical Applications. | Cancer Treat Res | 2024 | https://conductscience.org/library/papers/39212927 | PubMed |
| 39,100,666 | Efficacy and safety of PD-1/L1 inhibitors as first-line therapy for metastatic colorectal cancer: a meta-analysis. | Front Immunol | 2024 | https://conductscience.org/library/papers/39100666 | PubMed |
1 to 10 of 241
See all 241 cited byGenes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IK | 3,550 | PubTator's text mining | https://conductscience.org/library/genes/3550 | NCBI Gene |
| TP53 | 7,157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8030745
GET https://conductscience.org/api/papers/v1/8030745/references?page=2